SCLX
Scilex Holding Company
NASDAQ: SCLX · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$10.52
+21.76% today
Updated 2026-04-30
Market cap
$47.05M
P/E ratio
—
P/S ratio
1.56x
EPS (TTM)
$-36.48
Dividend yield
—
52W range
$4 – $34
Volume
0.0M
WallStSmart proprietary scores
21
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F4.5
Quality
C3.0
Profitability
D6.7
Valuation
B2/9
Piotroski F-Score
Weak
-20.6
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$490.00
+4557.79%
12-Month target
—
—
Intrinsic (DCF)
$18.45
Margin of safety
+55.23%
Price chart
X-Ray snapshot
Strengths
+ 55.23% below intrinsic value
+ Debt/equity -0.38x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Altman Z -20.64 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-18.01M
- Revenue declining -67.80% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $38.03M | $46.74M | $56.59M | $30.25M | $30.25M |
| Net income | $-23.36M | $-114.33M | $-72.81M | $-358.73M | $-33.11M |
| EPS | — | — | — | — | $-36.48 |
| Free cash flow | $-23.32M | $-21.04M | $18.75M | $3.68M | $-18.01M |
| Profit margin | -61.43% | -244.59% | -128.66% | -1,185.78% | — |
Peer comparison
Smart narrative
Scilex Holding Company trades at $10.52. Our Smart Value Score of 21/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -20.64, it sits in the distress. TTM revenue stands at $30.25M. Our DCF model estimates intrinsic value at $18.45.
Frequently asked questions
What is Scilex Holding Company's stock price?
Scilex Holding Company (SCLX) trades at $10.52.
Is Scilex Holding Company overvalued?
Smart Value Score 21/100 (Grade F, Strong Sell). DCF value $18.45.
What is the price target of Scilex Holding Company (SCLX)?
The analyst target price is $490.00, representing +4557.8% upside from the current price of $10.52.
What is the intrinsic value of Scilex Holding Company (SCLX)?
Based on our DCF model, intrinsic value is $18.45, a +55.2% margin of safety versus $10.52.
What is Scilex Holding Company's revenue?
TTM revenue is $30.25M.
Piotroski F-Score?
2/9 — weak financial health.
Altman Z-Score?
-20.64 — distress.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - GENERAL
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.56x
ROE—
Beta1.42
50D MA$7.56
200D MA$14.01
Shares out0.01B
Float0.00B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—